Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
110
Frequently Asked Questions
What is Market Cap of Neumora Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Neumora Therapeutics Inc. market cap is $268.83M.
What is the 52-week high for Neumora Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neumora Therapeutics Inc. 52 week high is $17.19 as of September 13, 2025.
What is the 52-week low for Neumora Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neumora Therapeutics Inc. 52 week low is $0.611 as of September 13, 2025.
What is Neumora Therapeutics Inc. stock price today?
Neumora Therapeutics Inc. stock price today is $1.62.
What was Neumora Therapeutics Inc. stock price yesterday?
Neumora Therapeutics Inc. stock price yesterday was $1.66.
What is the PE ratio of Neumora Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Neumora Therapeutics Inc.’s P/E ratio is -1.06.
What is the Price-to-Book ratio of Neumora Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Neumora Therapeutics Inc. P/B ratio is 1.4700.
What is the 50-day moving average of Neumora Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Neumora Therapeutics Inc. 50-day moving average is $1.61.
How many employess does Neumora Therapeutics Inc. has?
